Asahi's high flux polysulfone membrane specially developed for CRRT with:
High permeability and sharp cut-off curve
Superior biocompatibility
Low albumin loss
Long filter life
Cureflo is intended for patients with renal failure who also suffer from severe complications, such as multiple organ failure or cardiac and circulatory problems, including cardiac insufficiency and edema, who are not adequately treated by intermittent dialysis therapy. Cureflo is used to correct and purify body fluid through continuous hemofiltration (normally in excess of 10 hrs.).
Microporous gradient structure (dense and homogenous inside surface and porous outside area) provides "High permeability" and "Sharp cut-off" features.
In-house data: Product: ACF-110W
Bovine blood, Ht=35%, TP=6.5g/dL, QB=100mL/min, Qf=10mL/min, n=1
The change of WBC, C3a and granulocyte elastase is very small during treatment.
Clinical data Patient: n=6
In-house data
Bovine blood, Ht=35%, TP=6.5g/dL, QB=100mL/min, Qf=10mL/min, 24 hrs circulation
In-house data
Bovine blood, Ht=35%, TP=6.5g/dL, QB=200mL/min, Qf=30mL/min, n=2, 30 hrs circulation
Specification | ACF-130W | ACF-180W | |
---|---|---|---|
Hollow Fiber | Material | Polysulfone | |
Inside Diameter | 200 μm | ||
Wall Thickness | 45 μm | ||
Effective Surface Area | 1.3 m2 | 1.8 m2 | |
Priming Volume | 80 mL | 108 mL | |
Max. TMP | 66 kPa (500 mmHg) | ||
Sterilization | Gamma-Ray |
Specification | ACF-110W | |
---|---|---|
Hollow Fiber | Material | Polysulfone |
Inside Diameter | 200 μm | |
Wall Thickness | 45 μm | |
Effective Surface Area | 1.1 m2 | |
Priming Volume | 66 mL | |
Max. TMP | 66 kPa (500 mmHg) | |
Sterilization | Gamma-Ray |
In-house data
Bovine blood, Ht=32%, TP=6.0g/dL
In-house data: Product: ACF-110W
Bovine blood, Ht=35%, TP=6.5g/dL, QB=100mL/min, Qf=10mL/min, n=1